|
Volumn 10, Issue 4, 2005, Pages 520-524
|
Inhaled corticosteroid for persistent cough following upper respiratory tract infection
|
Author keywords
Chronic cough; Inhaled corticosteroid; Upper respiratory tract infection
|
Indexed keywords
ANTITUSSIVE AGENT;
BECLOMETASONE DIPROPIONATE;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
BUDESONIDE;
CORTICOSTEROID;
METHACHOLINE;
MUCOLYTIC AGENT;
PLACEBO;
BRONCHODILATING AGENT;
ADULT;
ARTICLE;
BRONCHUS HYPERREACTIVITY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORTICOSTEROID THERAPY;
COUGHING;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
FEMALE;
FORCED EXPIRATORY VOLUME;
HUMAN;
MALE;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
PROVOCATION TEST;
RANDOMIZED CONTROLLED TRIAL;
RESOURCE ALLOCATION;
SPIROMETRY;
SYMPTOMATOLOGY;
THORAX RADIOGRAPHY;
TREATMENT FAILURE;
UPPER RESPIRATORY TRACT INFECTION;
INHALATIONAL DRUG ADMINISTRATION;
LUNG FUNCTION TEST;
MICROBIOLOGY;
MIDDLE AGED;
RESPIRATORY TRACT INFECTION;
ADMINISTRATION, INHALATION;
ADULT;
BRONCHIAL HYPERREACTIVITY;
BRONCHODILATOR AGENTS;
BUDESONIDE;
COUGH;
DOUBLE-BLIND METHOD;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PROSPECTIVE STUDIES;
RESPIRATORY FUNCTION TESTS;
RESPIRATORY TRACT INFECTIONS;
TREATMENT FAILURE;
|
EID: 33644843968
PISSN: 13237799
EISSN: 14401843
Source Type: Journal
DOI: 10.1111/j.1440-1843.2005.00732.x Document Type: Article |
Times cited : (17)
|
References (20)
|